Celldex Therapeutics (CLDX) Q2 2019 Earnings

7MayConfirmed
Q3 2018
Q4 2018
Q1 2019
Q2 2019
-2.22
-1.68
-1.14
-0.6

Details

Expected EPS
-1.14
Actual EPS
-1.4
Surprise EPS
-0.26
Surprise Percent
+22.81%

Description

Celldex Therapeutics (CLDX) has reported earnings of -1.4 per share for Q2 2019.

0 Comments

Share your thoughts